Health Trials

Acupoint TENS vs Resistance Training for Iron Deficiency Anemia

ConditionIron Deficiency Anemia
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age20-30
SponsorCairo University

About this trial

The current study is designed to compare between the effect of transcutaneous electrical acupoint stimulation and resistance exercises on hemoglobin level in women with iron deficiency anemia.The design of this study will be a randomized controlled trial (RCT) pretest post-test assessment.Sixty women diagnosed with iron deficiency anemia will be recruited in this study from Kafrelshiekh University Hospital, Kafrelshiekh Governorate, Egypt. Their ages will be ranged from 20 to 30 years old, and they will be randomly divided into three equal (n= 20) groups. Change in hemoglobin concentration (g/dL) after the intervention period and changes in RBC count, MCV, MCH, RDW, serum ferritin, fatigue level, and functional exercise capacity after treatment will be measured.

Eligibility criteria

Qualifiers

Sixty women diagnosed with iron deficiency anemia within ≤6 months.

Their hemoglobin concentrations ranging from 8.0 to 10.9 g/dL that classified as moderate anemia in accordance with the World Health Organization (WHO) criteria.

The iron deficiency anemia resulted from the heavy monthly bleeding of menstrual cycle as reported by the women.

Their age will be ranged from 20 and 30 years old.

Disqualifiers

Other causes of anemia (e.g., hemolytic anemia, anemia of chronic disease, megaloblastic anemia, thalassemia, or sickle cell disease).

Severe anemia (hemoglobin < 8.0 g/dL)

History of chronic kidney disease, liver disease, or malignancy.

Current pregnancy or lactation, due to altered iron metabolism and hemoglobin thresholds.

Trial design

Treatments tested in this trial

  • Acupuncture transcutaneous electrical nerve stimulation (Acu-TENS)
  • Resistance exercise training
  • Ferrous Sulfate
  • Iron-rich diet with vitamin C
  • Avoidance of iron absorption inhibitors

Treatment groups

60 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Cairo University

Lead sponsor

Kafrelsheikh University

Sponsor institution

Kafrelsheikh University

Collaborator

Source ClinicalTrials.gov